- Home
- GDTC vs NTIP Comparison
GDTC vs NTIP Comparison
Compare GDTC & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- NTIP
- Stock Information
- Founded
- GDTC 2018
- NTIP 1990
- Country
- GDTC Singapore
- NTIP United States
- Employees
- GDTC N/A
- NTIP N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- NTIP Multi-Sector Companies
- Sector
- GDTC Health Care
- NTIP Miscellaneous
- Exchange
- GDTC Nasdaq
- NTIP Nasdaq
- Market Cap
- GDTC 28.0M
- NTIP 28.6M
- IPO Year
- GDTC 2023
- NTIP 1998
- Fundamental
- Price
- GDTC $2.03
- NTIP $1.41
- Analyst Decision
- GDTC Buy
- NTIP
- Analyst Count
- GDTC 1
- NTIP 0
- Target Price
- GDTC $5.00
- NTIP N/A
- AVG Volume (30 Days)
- GDTC 8.8K
- NTIP 29.5K
- Earning Date
- GDTC 01-01-0001
- NTIP 08-11-2025
- Dividend Yield
- GDTC N/A
- NTIP 7.25%
- EPS Growth
- GDTC N/A
- NTIP N/A
- EPS
- GDTC N/A
- NTIP N/A
- Revenue
- GDTC $368,838.00
- NTIP $250,000.00
- Revenue This Year
- GDTC $5.37
- NTIP N/A
- Revenue Next Year
- GDTC N/A
- NTIP N/A
- P/E Ratio
- GDTC N/A
- NTIP N/A
- Revenue Growth
- GDTC N/A
- NTIP N/A
- 52 Week Low
- GDTC $1.20
- NTIP $1.16
- 52 Week High
- GDTC $4.05
- NTIP $1.78
- Technical
- Relative Strength Index (RSI)
- GDTC 40.10
- NTIP 68.79
- Support Level
- GDTC $2.01
- NTIP $1.27
- Resistance Level
- GDTC $2.22
- NTIP $1.42
- Average True Range (ATR)
- GDTC 0.10
- NTIP 0.07
- MACD
- GDTC -0.02
- NTIP 0.02
- Stochastic Oscillator
- GDTC 8.57
- NTIP 96.15
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.